<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"><html xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>1471-2407-4-98.fm</title>
<meta name="Author" content="csproduction"/>
<meta name="Creator" content="FrameMaker 7.0"/>
<meta name="Producer" content="Acrobat Distiller 5.0.5 (Windows)"/>
<meta name="CreationDate" content=""/>
</head>
<body>
<pre>
BMC Cancer

BioMed Central

Open Access

Research article

ACRATA: a novel electron transfer domain associated to apoptosis
and cancer
Luis Sanchez-Pulido1, Ana M Rojas1, Alfonso Valencia1, Carlos Martinez-A2
and Miguel A Andrade*3,4
Address: 1Protein Design Group, Centro Nacional de Biotecnología (CNB-CSIC), Cantoblanco, Madrid, E-28049, Spain, 2Departamento de
Inmunologia y Oncologia DIO, Centro Nacional de Biotecnología (CNB-CSIC), Cantoblanco, Madrid, E-28049, Spain, 3Ontario Genomics
Innovation Centre, Ottawa Health Research Institute, 501 Smyth Road, Box 411, Ottawa, ON K1H 8L6, Canada and 4Department of Cellular and
Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada
Email: Luis Sanchez-Pulido - sanchez@cnb.uam.es; Ana M Rojas - arojas@cnb.uam.es; Alfonso Valencia - valencia@cnb.uam.es;
Carlos Martinez-A - cmartineza@cnb.uam.es; Miguel A Andrade* - mandrade@ohri.ca
* Corresponding author

Published: 29 December 2004
BMC Cancer 2004, 4:98

doi:10.1186/1471-2407-4-98

Received: 05 October 2004
Accepted: 29 December 2004

This article is available from: http://www.biomedcentral.com/1471-2407/4/98
© 2004 Sanchez-Pulido et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract
Background: Recently, several members of a vertebrate protein family containing a six transmembrane (6TM) domain and involved in apoptosis and cancer (e.g. STEAP, STAMP1, TSAP6), have
been identified in Golgi and cytoplasmic membranes. The exact function of these proteins remains
unknown.
Methods: We related this 6TM domain to distant protein families using intermediate sequences
and methods of iterative profile sequence similarity search.
Results: Here we show for the first time that this 6TM domain is homolog to the 6TM heme
binding domain of both the NADPH oxidase (Nox) family and the YedZ family of bacterial
oxidoreductases.
Conclusions: This finding gives novel insights about the existence of a previously undetected
electron transfer system involved in apoptosis and cancer, and suggests further steps in the
experimental characterization of these evolutionarily related families.

Background
A family of vertebrate proteins containing a six transmembrane domain (6TM) has been recently implicated in
apoptosis and cancer. Up to date, this family contains four
vertebrate members: STEAP, STAMP1/STEAP2, TIARP and
TSAP6/pHyde. STEAP (six-transmembrane epithelial antigen of the prostate) was the first described member of this
family and identified as a prostate-specific cell-surface
antigen overexpressed in cancer, located at the cell-cell
junction of the secretory epithelium of prostate, and

found as well in both colon and bladder cancer cell lines
[1,2]. STAMP1 (six transmembrane protein of prostate 1),
also known as STEAP2, also overexpressed in prostate cancer, has been located in the trans-Golgi network and shuttles to plasma membranes, which suggest a role in the
secretory/endocytic pathways [3,4]. TIARP (Tumor necrosis factor-alpha-induced adipose-related protein) is a cell
surface protein induced by TNF-α and IL-6, probably
implicated in resistance to insulin [5,6]. TSAP6 (tumor
suppressor activated pathway-6), also known as pHyde

Page 1 of 6
(page number not for citation purposes)

BMC Cancer 2004, 4:98

YEDZ_ECOLI
Y986_PSESM
YAH5_PSEPK
YAJ1_PSEAE
Y538_PASMU
YG46_XANAC
Y1G5_BORBR
YT80_RALSO
YR47_CAUCR
Y304_BRUME
YD82_RHIME
YJ20_AGRT5
YP37_DEIRA
Q7NFG8_Glovi
Q8YN59_Anasp
Q97LK5_Cloac
Y572_TREPA
STEA_HUMAN
Q8NFT2_STEAP2_Homsa
Q86SF6_TSAP6_Homsa
Q91W31_TIARP_Musmu
Q6PAY4_Xenla
Q6P7H1_Xenla
Q12209_L2114_Sacce
YGR0_YEAST
C24B_HUMAN
NOX1_HUMAN
Q8J0N4_noxA_Emeni
Q9XYS3_Dicdi
Q7Z7G3_NOX4_Homsa
Q86MX0_Dicdi
O61213_Caeel
Q9VQH2_Drome
Q9NRD9_DUOX1_Homsa
Q9UHF9_Homsa
Q9V7N2_Drome
Q96PH1_Homsa
P92950_FRO1_Arath
P92949_FRO2_Arath
FRE2_YEAST
FRE3_YEAST
FRE4_YEAST
FRE5_YEAST
FRE6_YEAST
FRE1_YEAST
FREL_CANAL
FRP1_SCHPO
FRE7_YEAST
Q8YTT0_Anasp
YE62_ARCFU

71
66
66
66
68
77
74
74
78
78
74
77
71
82
273
91
87
155
296
296
284
283
284
146
130
94
95
91
95
99
659
1067
1047
1124
783
339
308
203
213
310
310
303
304
317
288
269
151
191
80
29

http://www.biomedcentral.com/1471-2407/4/98

*

*

PLLIRTRRLLGLWCFAWATLHLTSYALLELGV..................................NNLALLGKELITRPYLTLGIISWVILLALAFTSTQAMQRK.LG.KHWQQLH.NFVYLVAI.LAPIHYL
PGWIVVRRQLGLWCFAYVVLHMTMYALFILG...................................LDWGQLGVELVKRPYIIVGALAFLGLLALAVTSNRYSQRR.LG.SRWKKLH.RLVYVILG.LGLLHMF
SGWIVVRRQLGLWVFAYIVLHILCYLFFILG...................................LDWGQLAVELRKRPYIIVGALGFLGLLVLAVTSNRYSQRR.LG.ARWKKLH.RLVYAVLG.LGLLHFL
PGWIAVRRQLGLWCFTYVLLHLSAYYVFILG...................................LDWGQLGIELSKRPYIIVGMLGFVCLFLLAITSNRFAMRK.LG.SRWKKLH.RLVYLILG.LGLLHML
PQLQVLRRALGLWAWFYVVLHVYAYLALELG...................................YDFSLFVQELVNRGYLIIGAIAFLILTLMALSSWSYLKLK.MG.KWWFYLH.QLGYYALL.LGAIHYV
AVVIRFRRMLGLYAFFYATVHLAAYLTLDLR...................................GFWTQIFEEILKRPYITVGFAAWLLLMPLAITSTQGWMRR.LK.RNWGRLH.MLIYPIGL.LAVLHFW
PALVRLRRMCGLFAFFYGSLHFLAWVWWDRG...................................LDPVSMLQDVGERPFITVGFAAFVLMAALAATSTQWAMRK.LG.KRWQVLH.RAVYAIGL.LAILHFW
NWLIRIRRMLGLYTFFYGTLHFLIWLLVDRG...................................LDPASMVKDIAKRPFITVGFAAFVLMIPLAATSTNAMVRR.LGGRRWQWLH.RLVYVTGV.LGILHYW
PRLVRFRRTVGLFAFAYVALHLLAYVGIDL...................................FFDWNQLWKDILKRPFITLGMLGFMLLIPLAVTSTNGWVIR.MGRAAWSRLH.RLVYLIVP.LGVAHYY
ITLLRYRRALGLLAFYYALMHFTTYMVLDQG...................................LNLSAIITDIVRRPFITIGMISLALLVPLALTSNNWSIRK.LG.RRWSSLH.KLVYIAIA.GSAVHFL
VNWLRYRRALGLLAFYYVMMHFLTYMVLDQT...................................LLLPAIVADIARRPFITIGMAALVLLIPLAVTSNIWSIRR.LG.QRWNKLH.RLVYVIAA.AGALHFA
VNLIAYRRALGLIAFYYVLAHFTVYLVLDRG...................................LILGSIAGDILKRPYIMLGMAGLIILIPLALTSNRWSIRR.LG.SRWNTLH.KLVYLVLI.VGVLHFV
TWAARIRKALGLLAAFYAVLHFGIYLRGQD....................................FSLGRIWEDVTERPFITSGFAALLLLLPLVLTSGKGSVRR.LGFARWTLLH.RLVYLAAA.LGALHYW
PGLLQERRYLGLLTFAFSVLHTWSQIEH..................................VLGGSLDGMFFLPRDMQFGVELGIFALLAMLPLALTSTDWAVRT.LK.GAWKGLH.QGVFFAAF.LIVLHTL
ASPLNYRRALGVGAFVLSVVHTTHMIQHS..................................LDWNFAAFFFLPPQFQIGMAAGAVALILMTPAAFTSWESWQKS.LG.KYWRQIH.LLSVPALL.LSAIHAV
KKLVAIRAQMAIMASIFIFPHVCIYLYYVLK...............................YTFPEVIDKGSIELFTAAYILAGIIAFIIMMPLFITSLK.KVRRKMNGVKWKKLQ.RWAYLFYL.LVYGHIL
QRVMGLRAELAITAAILTLGHNIAH..................................GRDYLVRLCGSTGDLSTGFLVAGAVSMVLVLLMSILAVTSFK.VVRRRMGAKTWKRVQ.RLAYLFYG.LTYVHLS
DKWMLTRKQFGLLSFFFAVLHAIYSLSYPMRRSYRYKLLN................WAYQQVQQNKEDAWIEHDVWRMEIYVSLGIVGLAILALLAVTSIP.SVSDSLTWREFHYIQSKLGIVSLL.LGTIHAL
ETWLQCRKQLGLLSFFFAMVHVAYSLCLPMRRSERYLFLN................MAYQQVHANIENSWNEEEVWRIEMYISFGIMSLGLLSLLAVTSIP.SVSNALNWREFSFIQSTLGYVALL.ISTFHVL
DHWLQHRKQIGLLSFFCAALHALYSFCLPLRRAHRYDLVN................LAVKQVLANKSHLWVEEEVWRMEIYLSLGVLALGTLSLLAVTSLP.SIANSLNWREFSFVQSSLGFVALV.LSTLHTL
DHWMLCRKQLGLVALGFAFLHVIYTLVIPIRYYVRWRLRN................ATITQALTNKDSPFITSYAWINDSYLALGILGFFLFLLLGITSLP.SVSNMVNWREFRFVQSKLGYLTLV.LCTAHTL
DTWMLCRKQLGLVALAYAFLHAIYTLVMPIRYYVRWWSNN................YIITQIKTNNTYEFLNYYAWLSDSYVALGILGFFFYVLLGITSLP.SVSNAVNWREFRFVQSKLGYLTLV.LCTAHTL
DQWMLCRKQLGLIALSYALLHAIYTLVIPIRYYVRYRINS................NIITQILKNETRTFDNTLAWRTDAYIALGILGFFFYVLLGITSLP.SVSNAVNWREFRFVQSKLGYLTLV.LCTGHAL
LALLPLHKWISRIVVLESILHTWFYL......................................YYMYINDTLYVKMRKLPNIYGVIALGLFLLIAITSVR.YARR.WSYRVFYYVH.YVSTWLILVFLHYHAR
TDFIPFHKWFSRIITVIGLLHGIFFIIKW...................................AIDDNVSLKQKLILKTFNFAGFIISILVLFLLICSIG.PMRR.YNYRLFYIVH.NLVNVAFILLTPIHSR
DRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTK.TIRR.SYFEVFWYTH.HLFVIFFI.GLAIHGA
DHNLTFHKLVAYMICLHTAIHIIAHLFNFDCYSRSRQATDGSLASILSSLSHDEK.KGGSWLNPIQSRNTTVEYVTFTSIAGLTGVIMTIALILMVTSATE.FIRR.SYFEVFWYTH.HLFIFYIL.GLGIHGI
DENIWFHRQVAYATLVFTILHVAAHYVNFYN..............................IERKQLRPETALQIHYAQPAGVTGHVMLFCMMLMYTTAHH.RIRQ.QSFETFWYTH.HLFIPFLL.GLYTHAT
DKNIVFHKLIAWVICFATFGHVMAHFNNFRLYQDITP..................QEYKRILGIDYPNLTPIKYA.FATLAGWTGHVVCIVMVLMYTSAVE.SIRR.PMFEGFWYTH.HLFVVFFG.LLVVHGL
DKSRTFHITCGVTICIFSGVHVAAHLVNALNFSVNYSED...................FVELNAARYRDEDPRKLLFTTVPGLTGVCMVVVLFLMITASTY.AIRV.SNYDIFWYTH.NLFFVFYM.LLTLHVS
DKYMTFHKLIGYTLIIASFLHTIGWIVGMAVATGKPDN..................IFYDCLAPHFKFRPTVWEMIFNSLPGVTGFIMISFLIIMAILSLK.IIRK.SNFELFYYSH.HLFIGFYV.LLILHGT
DSAIAFHKIVALFAAFWATLHTVGHCVNFYHVGTQSQEGLAC...............LFQEAFFGSNFLPSISYWFFSTITGLTGIALVAVMCIIYVFALP.CFIK.RAYHAFRLTH.LLNIAFYA.LTLLHGL
DSHIQFHKIAACTALFFSVLHTVGHIVNFYHVSTQSHENLRC...............LTREVHFASDYKPDITFWLFQTVTGTTGVMLFIIMCIIFVFAHP.TIRK.KAYNFFWNMH.TLYIGLYL.LSLIHGL
DAAVDFHRLIASTAIVLTVLHSVGHVVNVYLFSISPLSVLSC.............LFPGLFHDDGSELPQKYYWWFFQTVPGLTGVVLLLILAIMYVFASH.HFRR.RSFRGFWLTH.HLYILLYV.LLIIHGS
DAAVDFHRWIAMAAVVLAILHSAGHAVNVYIFSVSPLSLLAC.............IFPNVFVNDGSKLPQKFYWWFFQTVPGMTGVLLLLVLAIMYVFASH.HFRR.RSFRGFWLTH.HLYILLYA.LLIIHGS
DHHVYLHKLTGITISVLSLIHTIMHLFNFSIIVINDPNI................NAGHYTIGEWLLTDRPGLFGLIPGCANPTGVALLAILVVMFVCSQP.FVRRKGSFEVFYWTH.LLYVPFWI.LCLFHGP
DQNIQFHQLMGYVVVGLSLVHTVAHTVNFVLQAQA....................EASPFQFWELLLTTRPGIGW.VHGSASPTGVALLLLLLLMFICSSS.CIRRSGHFEVFYWTH.LSYLLVWL.LLIFHGP
ESSIKYHIWLGHLVMIIFTSHGLCYFIYW.................................ISKNQLVSKMLEWDRTAVSNLAGEIALVAGLMMWVTTYP.KIRR.RLFEVFFYSH.YLYIVFML.FFVFHVG
ESSIKYHIWLGHMVMALFTVHGLCYIIYW..................................ASMHEISQMIMWDTKGVSNLAGEIALAAGLVMWATTYP.KIRR.RFFEVFFYTH.YLYIVFML.FFVLHVG
TSFIMFHKWLGRMMFLDAMIHGSAYT......................................SYTVANKTWATSKNRLYWQFGVAALCLAGTMVFFSFA.VFRK.YFYEAFLFLH.IVLGAMFFYACWEHVV
TSFIMFHKWLGRMMFLDAVIHGAAYT......................................SYSVFYKDWAASKEETYWQFGVAALCIVGVMVFFSLA.MFRK.FFYEAFLFLH.IVLGALFFYTCWEHVV
TSFIVFHKWLGRMMFLDAIIHAAGFT......................................NYYLYYKKWNTVRLRVYWKFGIATTCLAGMLIFFSIA.AFRR.HYYETFMALH.IVFAALFLYTCWEHVT
TAFITYHKWLGRFMLVDCTIHAIGYT......................................YHAYIENYWKYVKYSDLWTSGRHAMIIVGILVFFSFF.FFRR.HYYELFVITH.IILAIGFFHACWKHCY
NSFISFHKWIGRIMVLNATIHSLSYS......................................LFAIINHAFKISNKQLYWKFGIASITVLCVLLVLSLG.IVRK.RHYEFFLYTH.IILALLFFYCCWQHVK
STFNFYHKWSAYVCFMLAVVHSIVMTASGVKR......................................GVFQSLVRKFYFRWGIVATILMSIIIFQSEK.VFRN.RGYEIFLLIH.KAMNIMFIIAMYYHCH
ATFIMYHRWISRVDVLLIIVHAITFSVS......................................DKATGKYKNRMKRDFMIWGTVSTICGGFILFQAML.FFRR.KCYEVFFLIH.IVLVVFFVVGGYYHLE
EKMNYVHRRLSQYAIMIGAIHGFAYI........................................GLAAQGKRALLTARVTIIGYVILGLMVIMIVSSLP.FFRR.RFYEWFFVLH.HMCSIGFLITIWLHHR
EKINIYHQWASILCLFFSWVHVIPFLRQARH..................................EGGYERMHQRWKASDMWRSGVPPILFLNLLWLSSLP.IARR.HFYEIFLQLH.WILAVGFYISLFYHVY
DLILQFHRYTSIVAFLFLLAHPIILFINN.................................PETLQLLNFFQAPWRAR....AAVIATLALIAIIVTSIW.RKQLNIGYENWRIAH.GILAVIIVSFGLGHVL
SYIVKAHRLFGYISVGFLLFHPLLEVLPR..............................QFEGSIQPFDAFWKIITTDNSAILLGIAGWAVMLTLAVTSVL.RKRLFKNYRKWRTFH.GILAVVLITVVGYHVL
TM III

TM IV

166
160
160
160
162
171
168
169
173
172
168
171
165
177
368
190
183
270
411
411
399
398
399
238
225
223
223
190
205
209
770
1181
1161
1240
899
453
417
299
308
402
402
395
396
409
380
361
241
287
174
130

TM V

Figure 1
Representative multiple alignment of the ACRATA domain
Representative multiple alignment of the ACRATA domain. It is viewed with the Belvu program [33]. The colouring
scheme indicates average BLOSUM62 score (correlated to amino acid conservation) in each alignment column: cyan (greater
than 3), light red (between 3 and 1.5) and light green (between 1.5 and 0.5). The limits of the domains are indicated by the residue positions on each side. The TMHMM helix transmembrane [29, 30] consensus prediction is shown below the alignment.
The asterisks above the alignment mark the conserved histidine residues mentioned in the text. Different groups of the
ACRATA sequences are shown by coloured lines to the left of the alignment: red, YedZ family; yellow, STEAP family; violet,
Nox family. The sequences are named with their swissprot or sptrembl identifiers, and also, if necessary, with their gene name.
Species abbreviations: Homsa, Homo sapiens; Glovi, Gloeobacter violaceus; Anasp, Anabaena sp.; Cloac, Clostridium acetobutylicum;
Musmu, Mus musculus; Xenla, Xenopus laevis; Sacce, Saccharomyces cerevisiae; Emeni, Emericella nidulans; Dicdi, Dictyostelium discoideum; Caeel, Caenorhabditis elegans; Drome, Drosophila melanogaster; Arath, Arabidopsis thaliana. Complementary information
is accessible at: http://www.pdg.cnb.uam.es/STEAP.

[7-10], is a p53 inducible protein which regulates apoptosis and the cell cycle via direct interaction with Nix (a proapoptotic Bcl-2 related protein) and Myt1 kinase (a negative regulator of the G2/M transition) [9]. TSAP6 has been
shown to be interacting with TCTP (Translationally controlled tumor protein) and could be implicated in its
secretion [10].
In this work we present evidence of remote homology of
this family to other two families: the mainly eukaryotic
Nox and the bacterial YedZ (Fig. 1), both involved in
redox functions [11-17]. The Nox family is involved in the
production of reactive oxygen species (ROS) [11,12]. The
first member of the family (gp91phox) was discovered in
phagocytes and contains an N-terminal transmembrane
heme binding domain and two C-terminal domains with
binding sites for both flavin adenine dinucleotide (FAD)

and NADPH (Fig. 2) [11-13]. Originally, ROS were
thought to be used just as a mechanism of host defence.
The discovery of gp91phox homologues in several other
tissues has suggested their implication in many other
functions, such us signal transduction, cancer, mitogenic
signalling, cellular growth, angiogenesis, and modification of extracellular matrix proteins [11-14]. Regarding
the bacterial YedZ family, the only experimentally characterized member so far is the Escherichia coli YedZ protein,
which binds a single heme and is involved in electron
transfer to the molybdopterin cofactor in YedY, its operon
neighbour gene [16-18]. The exact function of the operon
YedZ/YedY remains unknown.

Methods
To do the sequence analysis of the new domain we took
advantage of the possibility of connecting distant protein

Page 2 of 6
(page number not for citation purposes)

BMC Cancer 2004, 4:98

http://www.biomedcentral.com/1471-2407/4/98

A

YEDZ

A

ACRATA
F420_oxidored

TSAP6

NOX1
NOX5
DUOX1

FAD_binding_6

efhand

A

420

A

F

E E E E

P

N

A
E E

N
E

An_peroxidase

HMMer E−values / Uniref 90%

F

NAD_binding_1

A

STEAP

420

P

F

A

0.00087
0.63

N
F

N

Figure 2
ACRATA representation of the domain architecture and
common features
Schematic domain in representative proteins containing the
Schematic representation of the domain architecture and common features in representative proteins
containing the ACRATA domain. The representative
sequences selected correspond to: YEDZ,
SW:YEDZ_ECOLI; STEAP, SW:STEA_HUMAN; TSAP6,
SP:Q80ZF3; NOX1, SW:NOX1_HUMAN; NOX5,
SP:Q96PH2; DUOX1, SP:Q9NRD9. NOX1, NOX5, and
DUOX1, belong to the Nox family. The proteins are drawn
approximately to scale. The domains are named and located
according to the Pfam and SMART protein domain databases
[34-37]. Abbreviations: SP, SPTREMBL; SW, SWISSPROT.

families via intermediate sequences [19] and methods of
iterative profile sequence similarity search: HMMer
[20,21] and PSI-BLAST [22] over the Uniprot 90% non
redundant sequence database [23]. We used NAIL to view
and analyse the HMMer results [24]. The alignment of
transmembrane regions using standard substitution
matrices might be inaccurate because of the different roles
played by amino acids in globular proteins and in transmembrane media [25]. In the case of the ACRATA
domain, the regions to be aligned mostly consist of amino
acids located in transmembrane regions (Fig. 1). For this
reason, we used a method based on a hidden Markov
model (HMMer hmmalign), which does not rely on a general substitution matrix [20,21], using as a guide both the
transmembrane predictions from TMHMM [26,27] and
the results of multiple sequence alignment using T-Coffee
[28,29]. The genomic neighborhood of the bacterial
sequences (YedZ family) was analyzed to find potentially
related genes in operons using STRING [17,18].

Results
The global hidden Markov profile [20,21] generated for
STEAP and related vertebrate proteins (STEAP family,
henceforth) localized the first bacterial sequence (SpTrembl Q7VKI9 from Haemophilus ducreyi) with an E-value

STEAP

YedZ

0.007

0.2

0.032

NOX
Figure
families E-Values between the ACRATA domain containing
HMMer 3
HMMer E-Values between the ACRATA domain containing families. The numbers correspond to HMMer Evalues from global profile search results [20, 21] that connect
independently each family with the others. The arrows indicate the profile search direction, for example: the YedZ family profile search finds sequences of the STEAP family with a
0.00087 E-value and the global profile of the YedZ/STEAP
families (dotted line) detected the Nox family with an E-value
of 0.032.

of 0.63. This protein belongs to the large YedZ family of
bacterial oxidoreductases. The corresponding YedZ global
profile detected the STEAP family (most similar member:
SpTrembl Q8IUE7, human STAMP1) with an E-value of
0.00087. The global profile of STEAP and YedZ detected
the Nox family with an E-value of 0.032 and the corresponding Nox global profile localized the YedZ family
with an E-value of 0.007 (Fig. 3). Only the regions from
transmembranes 3 to 5 were considered to build the profiles because the transmembranes 1, 2 and 6 are highly
variable among families. We have named this 6TM
domain the ACRATA domain after Apoptosis, Cancer and
Redox Associated TransmembrAne domain.
To investigate the consistency of our results we performed
iterative database searches using the PSI-BLAST program
[22]. We used as query the most conserved region of the
ACRATA domain in E. coli YedZ protein (residues 71–
166). These searches detected all of the ACRATA domaincontaining families after 15 iterations (using a cut-off of E
= 0.005 for the inclusion of retrieved sequences in the profile). None of these profile searches retrieved new

Page 3 of 6
(page number not for citation purposes)

BMC Cancer 2004, 4:98

0.05

http://www.biomedcentral.com/1471-2407/4/98

YEDZ_ECOLI
Y986_PSESM
YAH5_PSEPK
YAJ1_PSEAE
Y538_PASMU
YG46_XANAC
YR47_CAUCR
Y1G5_BORBR
YT80_RALSO
Y304_BRUME
YD82_RHIME
YJ20_AGRT5
YP37_DEIRA
Q7NFG8_Glovi
Q8YN59_Anasp
Q97LK5_Cloac
Y572_TREPA
STEA_HUMAN
Q8NFT2_STEAP2_Homsa
Q86SF6_TSAP6_Homsa
Q91W31_TIARP_Musmu
Q6PAY4_Xenla
Q6P7H1_Xenla
NOX1_HUMAN
C24B_HUMAN
Q8J0N4_noxA_Emeni
Q9XYS3_Dicdi
Q7Z7G3_NOX4_Homsa
Q86MX0_Dicdi
O61213_Caeel
Q9VQH2_Drome
Q9NRD9_DUOX1_Homsa
Q9UHF9_Homsa
Q9V7N2_Drome
Q96PH1_Homsa
P92950_FRO1_Arath
P92949_FRO2_Arath
Q12209_L2114_Sacce
YGR0_YEAST
FRE2_YEAST
FRE3_YEAST
FRE4_YEAST
FRE5_YEAST
FRE6_YEAST
FRE1_YEAST
FREL_CANAL
FRP1_SCHPO
FRE7_YEAST
Q8YTT0_Anasp
YE62_ARCFU

Figure
proteins4
Phylogenetic tree of selected ACRATA domain containing
Phylogenetic tree of selected ACRATA domain containing proteins. The scale bar represents the number of
inferred substitutions per 100 sites (amino acid residues).
The tree branches for YedZ proteins are in red, STEAP
branches are in yellow, and Nox branches are in violet.
Organism name abbreviations are as in Fig. 1. We generated
trees using a Bayesian, Neighbor Joining, and Minimum Evolution methods, and found that all three gave the same topology suggesting that the overall structure of the tree is
correct. For illustrative purposes only the Neighbor Joining
tree is shown [38-40].

unrelated sequences, and reciprocal searches produced
convergent results. Therefore, we have concluded that
ACRATA is a previously undetected, conserved domain
that is commonly found in members of the STEAP, YedZ
and Nox protein families. The similarity between these
proteins was suspected before [30]. However, no alignment, domain definition or substantial statistical evidence was provided to demonstrate the evolutionary
relationships of these proteins.

that the STEAP protein family could bind at least an heme
group, as was previously experimentally characterized for
Nox and YedZ families [13,16], or for other analogous
proteins such as cytochromes [31].

Discussion
Experimental evidence show that Nox and YedZ families
share heme binding capabilities and also involvement in
electron transfer chains [11-13,16]. For the STEAP family,
the electron transfer capability is consistent with the presence of an N-terminal cytoplasmic NADP oxidoreductase
coenzyme F420 dependent domain, being the only exception the STEAP protein itself (Fig. 2). Therefore we conclude that ACRATA domain is a heme binding 6TM
domain that originated before the onset of eukaryotes
(ancestral, YedZ), transmitted by vertical descent in a conventional manner (Nox family), and further expanded in
vertebrates (STEAP family) (Fig. 4).
Although the mechanism of action of the ACRATA
domain could be the same in all the proteins containing
it, its variable cellular role is made conspicuous by the different effects produced by the modifications in the expression of the corresponding genes. For example, the knockout of the whole YedYZ operon seems not to affect E. coli
in a number of conditions tested (Brokx, S.J. and Weiner,
J.H. personal communication). Very differently, changes
in the expression patterns of human genes containing the
ACRATA domain could be related with apoptosis or cancer [1-14]. The well known functional flexibility of oxidoreductases is exemplified in bacterial proteins such as
cupredoxins and cytochromes, normally involved in electron transfer during respiration but that can enter in
eukaryotic cells to induce apoptosis or inhibition of cell
growth [32], or in the Nox family, with functions as different as host defence in phagocytes or extracellular matrix
modification [11,12].

Conclusions
We have described for the first time a 6TM domain present
in three protein families (STEAP, YedZ and Nox): the
ACRATA domain. The common functions of the proteins
of those families suggest that this domain is involved in
electron transfer, mediated by its heme binding
capability. We hypothesize that STEAP, STAMP1, TSAP6,
and TIARP have this function, and that they form part of
electron transfer systems involved in cellular regulation,
apoptosis, and cancer. Additional experimental
approaches using different members of the ACRATA
domain-containing families are required to confirm these
hypotheses.

Abbreviations
The complete conservation of two histidines in all
ACRATA domain containing proteins (Fig. 1) indicates

STEAP, six-transmembrane epithelial antigen of the
prostate;

Page 4 of 6
(page number not for citation purposes)

BMC Cancer 2004, 4:98

http://www.biomedcentral.com/1471-2407/4/98

STAMP1, six transmembrane protein of prostate 1;
TSAP6, tumor suppressor activated pathway-6;
TIARP, Tumor necrosis factor-alpha-induced adiposerelated protein;
TCTP, Translationally controlled tumor protein;
Nox, NADPH oxidase;

6.

7.
8.
9.

ROS, reactive oxygen species;
TM, Trans-membrane;

10.

FAD, flavin adenine dinucleotide;
11.

HMM, Hidden Markov Models;

12.

Competing interests

13.

The author(s) declare that they have no competing
interests.

14.

Authors' contributions
LSP, AMR, and MAA carried out the sequence analysis of
the domain.

15.

LSP and MAA provided with the initial input of the
research.

16.

LSP, AMR, AV, CMA, and MAA authored the manuscript.

17.

Acknowledgements

18.
19.

We are grateful to S.J. Brokx and J.H. Weiner (University of Alberta,
Edmonton, Canada) for useful comments on early versions of the manuscript. Thanks also to G.R. Reina and J. Menéndez (Hospital Puerta de
Hierro, Madrid, Spain) for their encouragement and moral support.

References
1.

2.

3.

4.

5.

Hubert RS, Vivanco I, Chen E, Rastegar S, Leong K, Mitchell SC,
Madraswala R, Zhou Y, Kuo J, Raitano AB, Jakobovits A, Saffran DC,
Afar DE: STEAP: a prostate-specific cell-surface antigen
highly expressed in human prostate tumors. Proc Natl Acad Sci
U S A 1999, 96:14523-14528.
Yang D, Holt GE, Velders MP, Kwon ED, Kast WM: Murine sixtransmembrane epithelial antigen of the prostate, prostate
stem cell antigen, and prostate-specific membrane antigen:
prostate-specific cell-surface antigens highly expressed in
prostate cancer of transgenic adenocarcinoma mouse prostate mice. Cancer Res 2001, 61:5857-5860.
Korkmaz KS, Elbi C, Korkmaz CG, Loda M, Hager GL, Saatcioglu F:
Molecular cloning and characterization of STAMP1, a highly
prostate-specific six transmembrane protein that is overexpressed in prostate cancer. J Biol Chem 2002, 277:36689-36696.
Porkka KP, Helenius MA, Visakorpi T: Cloning and characterization of a novel six-transmembrane protein STEAP2,
expressed in normal and malignant prostate. Lab Invest 2002,
82:1573-1582.
Moldes M, Lasnier F, Gauthereau X, Klein C, Pairault J, Feve B, Chambaut-Guerin AM: Tumor necrosis factor-alpha-induced adipose-related protein (TIARP), a cell-surface protein that is

20.
21.
22.

23.
24.
25.
26.

27.
28.
29.
30.
31.

highly induced by tumor necrosis factor-alpha and adipose
conversion. J Biol Chem 2001, 276:33938-33946.
Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, ChambautGuerin AM, Klein J, Paschke R: Interleukin-6 is a positive regulator of tumor necrosis factor alpha-induced adipose-related
protein in 3T3-L1 adipocytes. FEBS Lett 2004, 560:153-157.
Zhang X, Steiner MS, Rinaldy A, Lu Y: Apoptosis induction in
prostate cancer cells by a novel gene product, pHyde,
involves caspase-3. Oncogene 2001, 20:5982-5990.
Porkka KP, Nupponen NN, Tammela TL, Vessella RL, Visakorpi T:
Human pHyde is not a classical tumor suppressor gene in
prostate cancer. Int J Cancer 2003, 106:729-735.
Passer BJ, Nancy-Portebois V, Amzallag N, Prieur S, Cans C, Roborel
de Climens A, Fiucci G, Bouvard V, Tuynder M, Susini L, Morchoisne
S, Crible V, Lespagnol A, Dausset J, Oren M, Amson R, Telerman A:
The p53-inducible TSAP6 gene product regulates apoptosis
and the cell cycle and interacts with Nix and the Myt1 kinase.
Proc Natl Acad Sci U S A 2003, 100:2284-2289.
Amzallag N, Passer BJ, Allanic D, Segura E, Thery C, Goud B, Amson
R, Telerman A: TSAP6 facilitates the secretion of TCTP/HRF
via a non-classical pathway. J Biol Chem 2004, 279:46104-46112.
2004 Sep 21
Lambeth JD: NOX enzymes and the biology of reactive
oxygen. Nat Rev Immunol 2004, 4:181-189.
Geiszt M, Leto TL: The Nox family of NAD(P)H oxidases: Host
defense and beyond. J Biol Chem 2004, 279:51715-51718. 2004 Sep
13
Yu L, Quinn MT, Cross AR, Dinauer MC: Gp91(phox) is the heme
binding subunit of the superoxide-generating NADPH
oxidase. Proc Natl Acad Sci U S A 1998, 95:7993-7998.
Mitsushita J, Lambeth JD, Kamata T: The superoxide-generating
oxidase Nox1 is functionally required for Ras oncogene
transformation. Cancer Res 2004, 64:3580-3585.
Drew D, Sjostrand D, Nilsson J, Urbig T, Chin CN, de Gier JW, von
Heijne G: Rapid topology mapping of Escherichia coli innermembrane proteins by prediction and PhoA/GFP fusion
analysis. Proc Natl Acad Sci U S A 2002, 99:2690-2695.
Loschi L, Brokx SJ, Hills TL, Zhang G, Bertero MG, Lovering AL,
Weiner JH, Strynadka NC: Structural and biochemical identification of a novel bacterial oxidoreductase. J Biol Chem 2004,
279:50391-50400. 2004 Sep 7
von Mering C, Huynen M, Jaeggi D, Schmidt S, Bork P, Snel B:
STRING: a database of predicted functional associations
between proteins. Nucleic Acids Res 2003, 31:258-261.
STRING [http://string.embl.de/]
Park J, Teichmann SA, Hubbard T, Chothia C: Intermediate
sequences increase the detection of homology between
sequences. J Mol Biol 1997, 273:349-354.
Eddy SR: Profile hidden Markov models. Bioinformatics 1998,
14:755-763.
HMMer [http://hmmer.wustl.edu/]
Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of
protein database search programs. Nucleic Acids Res 1997,
25:3389-3402.
Apweiler R, Bairoch A, Wu CH: Protein sequence databases.
Curr Opin Chem Biol 2004, 8:76-80.
Sanchez-Pulido L, Yuan YP, Andrade MA, Bork P: NAIL-Network
Analysis Interface for Linking HMMER results. Bioinformatics
2000, 16:656-657.
Jones DT, Taylor WR, Thornton JM: A mutation data matrix for
transmembrane proteins. FEBS Lett 1994, 339:269-275.
Krogh A, Larsson B, von Heijne G, Sonnhammer EL: Predicting
transmembrane protein topology with a hidden Markov
model: application to complete genomes. J Mol Biol 2001,
305:567-580.
TMHMM [http://www.cbs.dtu.dk/services/TMHMM]
Notredame C, Higgins DG, Heringa J: T-Coffee: A novel method
for fast and accurate multiple sequence alignment. J Mol Biol
2000, 302:205-217.
T-COFFEE [http://www.ch.embnet.org/software/TCoffee.html]
TCDB [http://tcdb.ucsd.edu]
Walker FA: Models of the Bis-Histidine-Ligated ElectronTransferring Cytochromes. Comparative Geometric and
Electronic Structure of Low-Spin Ferro- and Ferrihemes.
Chem Rev 2004, 104:589-615.

Page 5 of 6
(page number not for citation purposes)

BMC Cancer 2004, 4:98

32.

33.
34.

35.
36.
37.
38.
39.
40.

http://www.biomedcentral.com/1471-2407/4/98

Yamada T, Hiraoka Y, Das Gupta TK, Chakrabarty AM: Regulation
of mammalian cell growth and death by bacterial redox proteins: relevance to ecology and cancer therapy. Cell Cycle 2004,
3:752-755.
BELVU
[http://www.sanger.ac.uk/Software/Pfam/help/
belvu_setup.shtml]
Bateman A, Coin L, Durbin R, Finn RD, Hollich V, Griffiths-Jones S,
Khanna A, Marshall M, Moxon S, Sonnhammer EL, Studholme DJ,
Yeats C, Eddy SR: The Pfam protein families database. Nucleic
Acids Res 2004, 32(Database):D138-D141.
PFAM [http://www.sanger.ac.uk/Software/Pfam/]
Letunic I, Copley RR, Schmidt S, Ciccarelli FD, Doerks T, Schultz J,
Ponting CP, Bork P: SMART 4.0: towards genomic data
integration. Nucleic Acids Res 2004, 32(Database):D142-D144.
SMART [http://smart.embl.de/]
Feng DF, Doolittle RF: Progressive alignment of amino acid
sequences and construction of phylogenetic trees from
them. Methods Enzymol 1996, 266:368-382.
Kumar S, Tamura K, Jakobsen IB, Nei M: MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 2001,
17:1244-1245.
Ronquist F, Huelsenbeck JP: MrBayes 3: Bayesian phylogenetic
inference under mixed models. Bioinformatics 2003,
19:1572-1574.

Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2407/4/98/prepub

Publish with Bio Med Central and every
scientist can read your work free of charge
"BioMed Central will be the most significant development for
disseminating the results of biomedical researc h in our lifetime."
Sir Paul Nurse, Cancer Research UK

Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central
yours — you keep the copyright

BioMedcentral

Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp

Page 6 of 6
(page number not for citation purposes)

</pre>
</body>
</html>
